Literature DB >> 32462562

Association of ABCB1 gene polymorphism (C1236T and C3435T) with refractory epilepsy in Iraqi patients.

Khalid S Salih1, Farqad B Hamdan2, Qasim S Al-Mayah3, Akram M Al-Mahdawi4.   

Abstract

The mechanisms of refractory epilepsy (RE) are most likely multifactorial, involving environmental, genetic, as well as disease- and drug-related factors. We aimed to study is to investigate the possible association of two ABCB1 gene polymorphism (C3435T and C1236T) with the development of RE in Iraqi patients. One hundred patients with either generalized tonic-clonic seizures, myoclonic epilepsy, or absence epilepsy comprised of 60 patients responsive to AEDs and 40 patients who were refractory to treatment who used multi AEDs for at least one month were studied. Fifty family-unrelated age- and sex-matched healthy subjects represent the control group. ABCB1 gene fragments corresponding to two targeted polymorphisms were amplified with conventional polymerase chain reaction using specific sets of primers. Genotyping was performed by restriction fragment length polymorphism (RFLP) technique. Epileptic patients refractory to AEDs showed a significantly higher frequency of CC genotypes of C3435T polymorphism than controls. Allele C was significantly higher in patients than controls and far more frequent among patients with RE. C1235T polymorphism had no significant role neither in the incidence of epilepsy nor in the AEDs resistance. The CT haplotype was more frequent among patients refractory to AEDs. In contrast, the haplotype block TT was more frequent among responsive (41.3%) than refractory patients (28.7%) (p = 0.068). The CC genotype and C allele of the C3435T polymorphism can increase the risk of RE. The haplotype block CT of C3435T and C1236T can predispose for epilepsy as well as the drug resistance.

Entities:  

Keywords:  ABCB1 gene; Iraqi; Refractory epilepsy

Mesh:

Substances:

Year:  2020        PMID: 32462562     DOI: 10.1007/s11033-020-05540-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  34 in total

1.  New developments in antiepileptic drug resistance: an integrative view.

Authors:  Dieter Schmidt; Wolfgang Löscher
Journal:  Epilepsy Curr       Date:  2009 Mar-Apr       Impact factor: 7.500

Review 2.  Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

Authors:  Lucy Sanchez-Covarrubias; Lauren M Slosky; Brandon J Thompson; Thomas P Davis; Patrick T Ronaldson
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 3.  ABC transporters in drug-refractory epilepsy: limited clinical significance of pharmacogenetics?

Authors:  I Cascorbi
Journal:  Clin Pharmacol Ther       Date:  2010-01       Impact factor: 6.875

4.  Epilepsy: new advances.

Authors:  Solomon L Moshé; Emilio Perucca; Philippe Ryvlin; Torbjörn Tomson
Journal:  Lancet       Date:  2014-09-24       Impact factor: 79.321

5.  Polymorphism of the multidrug resistance 1 gene MDR1/ABCB1 C3435T and response to antiepileptic drug treatment in temporal lobe epilepsy.

Authors:  Ida Manna; Antonio Gambardella; Angelo Labate; Laura Mumoli; Edoardo Ferlazzo; Franco Pucci; Umberto Aguglia; Aldo Quattrone
Journal:  Seizure       Date:  2014-10-02       Impact factor: 3.184

Review 6.  The clinical impact of pharmacogenetics on the treatment of epilepsy.

Authors:  Wolfgang Löscher; Ulrich Klotz; Fritz Zimprich; Dieter Schmidt
Journal:  Epilepsia       Date:  2008-07-08       Impact factor: 5.864

7.  Knockout of P-glycoprotein does not alter antiepileptic drug efficacy in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice.

Authors:  Marion Bankstahl; Sabine Klein; Kerstin Römermann; Wolfgang Löscher
Journal:  Neuropharmacology       Date:  2016-06-07       Impact factor: 5.250

8.  Validation of a P-Glycoprotein (P-gp) Humanized Mouse Model by Integrating Selective Absolute Quantification of Human MDR1, Mouse Mdr1a and Mdr1b Protein Expressions with In Vivo Functional Analysis for Blood-Brain Barrier Transport.

Authors:  Muhammad Waqas Sadiq; Yasuo Uchida; Yutaro Hoshi; Masanori Tachikawa; Tetsuya Terasaki; Margareta Hammarlund-Udenaes
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

Review 9.  Relationship between ABCB1 3435TT genotype and antiepileptic drugs resistance in Epilepsy: updated systematic review and meta-analysis.

Authors:  Malek Chouchi; Wajih Kaabachi; Hedia Klaa; Kalthoum Tizaoui; Ilhem Ben-Youssef Turki; Lamia Hila
Journal:  BMC Neurol       Date:  2017-02-15       Impact factor: 2.474

Review 10.  Drug-Resistant Epilepsy: Multiple Hypotheses, Few Answers.

Authors:  Fei Tang; Anika M S Hartz; Björn Bauer
Journal:  Front Neurol       Date:  2017-07-06       Impact factor: 4.003

View more
  1 in total

Review 1.  Pharmacogenetics of Carbamazepine and Valproate: Focus on Polymorphisms of Drug Metabolizing Enzymes and Transporters.

Authors:  Teresa Iannaccone; Carmine Sellitto; Valentina Manzo; Francesca Colucci; Valentina Giudice; Berenice Stefanelli; Antonio Iuliano; Giulio Corrivetti; Amelia Filippelli
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.